Advertisement

Coronary computed tomography angiography evaluation of plaque morphology and its relationship to HDL and total cholesterol to HDL ratio

      Highlights

      • Low HDL-C and high TC/HDL ratio are strongly associated with plaque characteristics.
      • Mechanistic evidence to support protective role of HDL-C and TC/HDL ratio.
      • Lipid ratios indicate atherogenic/antiatherogenic cholesterol balance.
      • TC/HDL indicates lipoprotein particle size/number disparity with cholesterol content.

      Abstract

      Background

      While population studies have demonstrated that high density lipoprotein cholesterol (HDL-C) and the ratio of total cholesterol to HDL (TC/HDL) improve cardiovascular risk prediction, the mechanism by which these parameters protect the cardiovascular system remains uncertain.

      Objective

      To investigate the relationship between the HDL-C level and the total cholesterol to HDL (TC/HDL) ratio with the morphology of coronary artery plaque as determined by coronary computed tomography angiography (CCTA).

      Methods

      This is a cross-sectional study involving 190 subjects with stable coronary artery disease. Semi-automated plaque analysis software was utilized to quantify plaque and plaque volumes are presented as total atheroma volume normalized (TAVnorm). Multivariate regression models were used to evaluate the association of HDL-C and TC/HDL ratio with coronary plaque volumes.

      Results

      Of the 190 subjects the average (SD) age was 58.9 (9.8) years, with 63% being male. After adjustment for cardiovascular risk factors, HDL- C (>40 mg/dl) is inversely associated with fibrous (p = 0.003), fibrous fatty (p = 0.007), low attenuation plaque (LAP) (p = 0.007), total non-calcified plaque (TNCP) (p = 0.002) and total plaque (TP)(p = 0.004) volume. Furthermore, the TC/HDL ratio (> 4.0) is associated with fibrous (p = 0.047) and total non-calcified plaque (p = 0.039), but not with fibrofatty, LAP, dense calcified plaque, or TP volume.

      Conclusion

      There is a strong association between low HDL-C levels and increasing TC/HDL ratio with certain types of coronary plaque characteristics, independent of traditional risk factors. The findings of this study suggest mechanistic evidence supporting the protective role of HDL-C and the TC/HDL ratio's clinical relevance in coronary artery disease management.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Roth G.A.
        • Mensah G.A.
        • Fuster V.
        The Global Burden of Cardiovascular Diseases and Risks: a Compass for Global Action.
        J Am Coll Cardiol. Dec 22 2020; 76: 2980-2981https://doi.org/10.1016/j.jacc.2020.11.021
        • Hadamitzky M.
        • Achenbach S.
        • Al-Mallah M.
        • et al.
        Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: an InteRnational Multicenter Registry).
        J Am Coll Cardiol. Jul 30 2013; 62: 468-476https://doi.org/10.1016/j.jacc.2013.04.064
        • Naoum C.
        • Berman D.S.
        • Ahmadi A.
        • et al.
        Predictive Value of Age- and Sex-Specific Nomograms of Global Plaque Burden on Coronary Computed Tomography Angiography for Major Cardiac Events.
        Circ Cardiovasc Imaging. Mar 2017; 10https://doi.org/10.1161/circimaging.116.004896
        • Ferencik M.
        • Mayrhofer T.
        • Bittner D.O.
        • et al.
        Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: a Secondary Analysis of the PROMISE Randomized Clinical Trial.
        JAMA Cardiol. Feb 1 2018; 3: 144-152https://doi.org/10.1001/jamacardio.2017.4973
        • Ference B.A.
        • Graham I.
        • Tokgozoglu L.
        • Catapano A.L.
        Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series.
        J Am Coll Cardiol. Sep 4 2018; 72: 1141-1156https://doi.org/10.1016/j.jacc.2018.06.046
        • Duncan M.S.
        • Vasan R.S.
        • Xanthakis V.
        Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: observations From the Framingham Study Over 35 Years.
        J Am Heart Assoc. Jun 4 2019; 8e011433https://doi.org/10.1161/jaha.118.011433
        • Domanski M.J.
        • Tian X.
        • Wu C.O.
        • et al.
        Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk.
        J Am Coll Cardiol. Sep 29 2020; 76: 1507-1516https://doi.org/10.1016/j.jacc.2020.07.059
      1. Gordon D.J., Probstfield J.L., Garrison R.J., et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. Jan 1989;79(1):8–15. doi:10.1161/01.cir.79.1.8

        • Quispe R.
        • Elshazly M.B.
        • Zhao D.
        • et al.
        Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: the ARIC study.
        Eur J Prev Cardiol. Oct 2020; 27: 1597-1605https://doi.org/10.1177/2047487319862401
        • Siddiqi H.K.
        • Kiss D.
        • Rader D.
        HDL-cholesterol and cardiovascular disease: rethinking our approach.
        Curr Opin Cardiol. Sep 2015; 30: 536-542https://doi.org/10.1097/HCO.0000000000000211
        • Reiner Z.
        Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
        Nutr Metab Cardiovasc Dis. Sep 2013; 23: 799-807https://doi.org/10.1016/j.numecd.2013.05.002
        • Calling S.
        • Johansson S.E.
        • Wolff M.
        • Sundquist J.
        • Sundquist K.
        The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women's health in the Lund area (WHILA): a 17-year follow-up cohort study.
        BMC Cardiovasc Disord. Oct 29 2019; 19: 239https://doi.org/10.1186/s12872-019-1228-7
        • Gimeno-Orna J.A.
        • Faure-Nogueras E.
        • Sancho-Serrano M.A
        Usefulness of total cholesterol/HDL-cholesterol ratio in the management of diabetic dyslipidaemia.
        Diabet Med. Jan 2005; 22: 26-31https://doi.org/10.1111/j.1464-5491.2004.01341.x
        • Barter P.
        • Gotto A.M.
        • LaRosa J.C.
        • et al.
        HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events.
        New England Journal of Medicine. 2007; 357 (2007/09/27): 1301-1310https://doi.org/10.1056/NEJMoa064278
        • Di Bartolo B.A.
        • Psaltis P.J.
        • Bursill C.A.
        • Nicholls S.J.
        Translating Evidence of HDL and Plaque Regression.
        Arterioscler Thromb Vasc Biol. Sep 2018; 38: 1961-1968https://doi.org/10.1161/ATVBAHA.118.307026
        • Pikula A.
        • Beiser A.S.
        • Wang J.
        • et al.
        Lipid and lipoprotein measurements and the risk of ischemic vascular events: framingham Study.
        Neurology. Feb 3 2015; 84: 472-479https://doi.org/10.1212/wnl.0000000000001202
        • Vitali C.
        • Khetarpal S.A.
        • Rader D.J.
        HDL Cholesterol Metabolism and the Risk of CHD: new Insights from Human Genetics.
        Curr Cardiol Rep. Nov 4 2017; 19: 132https://doi.org/10.1007/s11886-017-0940-0
        • Sone H.
        • Nakagami T.
        • Nishimura R.
        • Tajima N.
        • Group M.S.
        Comparison of lipid parameters to predict cardiovascular events in Japanese mild-to-moderate hypercholesterolemic patients with and without type 2 diabetes: subanalysis of the MEGA study.
        Diabetes Res Clin Pract. Mar 2016; 113: 14-22https://doi.org/10.1016/j.diabres.2015.12.002
        • Voight B.F.
        • Peloso G.M.
        • Orho-Melander M.
        • et al.
        Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.
        Lancet. Aug 11 2012; 380: 572-580https://doi.org/10.1016/S0140-6736(12)60312-2
        • Badimon J.J.
        • Badimon L.
        • Fuster V.
        Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.
        J Clin Invest. Apr 1990; 85: 1234-1241https://doi.org/10.1172/jci114558
        • Min J.K.
        • Dunning A.
        • Lin F.Y.
        • et al.
        Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: an InteRnational Multicenter) Registry.
        J Cardiovasc Comput Tomogr. Mar-Apr 2011; 5: 84-92https://doi.org/10.1016/j.jcct.2011.01.007
        • Nakanishi R.
        • Alani A.
        • Matsumoto S.
        • et al.
        Changes in Coronary Plaque Volume: comparison of Serial Measurements on Intravascular Ultrasound and Coronary Computed Tomographic Angiography.
        Texas Heart Institute J. 2018; 45: 84-91https://doi.org/10.14503/THIJ-15-5212
        • Zeb I.
        • Li D.
        • Nasir K.
        • et al.
        Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study.
        Atherosclerosis. Dec 2013; 231: 198-204https://doi.org/10.1016/j.atherosclerosis.2013.08.019
        • Lee J.
        • Nakanishi R.
        • Li D.
        • et al.
        Randomized trial of rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis.
        Am Heart J. Dec 2018; 206: 127-130https://doi.org/10.1016/j.ahj.2018.08.007
        • Nakanishi R.
        • Ceponiene I.
        • Osawa K.
        • et al.
        Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: a propensity-score matching study.
        Atherosclerosis. 2016; 255 (DEC): 73-79https://doi.org/10.1016/j.atherosclerosis.2016.11.004
        • Fahmy M.
        • Nakanishi R.
        • Matsumoto S.
        • et al.
        Inter-observer reproducibility in a novel semi-automated coronary plaque quantification software.
        J Cardiovasc Comput Tomogr. 2014; 8: S57
        • Grundy S.M.
        • Stone N.J.
        • Bailey A.L.
        • et al.
        PCNA Guideline on the Management of Blood Cholesterol: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        Circulation. 2018; 139 (. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/ 2019/06/18 2019): e1082-e1143https://doi.org/10.1161/CIR.0000000000000625
        • Nicholls S.J.
        • Tuzcu E.M.
        • Sipahi I.
        • et al.
        Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
        JAMA. Feb 7 2007; 297: 499-508https://doi.org/10.1001/jama.297.5.499
        • Lakshmanan S.
        • Shekar C.
        • Kinninger A.
        • et al.
        Association of high-density lipoprotein levels with baseline coronary plaque volumes by coronary CTA in the EVAPORATE trial.
        Atherosclerosis. Jul 2020; 305: 34-41https://doi.org/10.1016/j.atherosclerosis.2020.05.014
        • Caselli C.
        • De Graaf M.A.
        • Lorenzoni V.
        • et al.
        HDL cholesterol, leptin and interleukin-6 predict high risk coronary anatomy assessed by CT angiography in patients with stable chest pain.
        Atherosclerosis. 2015; 241 (2015/07/01/): 55-61https://doi.org/10.1016/j.atherosclerosis.2015.04.811
        • Elshazly M.B.
        • Nicholls S.J.
        • Nissen S.E.
        • et al.
        Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
        Am J Cardiol. Sep 1 2016; 118: 647-655https://doi.org/10.1016/j.amjcard.2016.06.021
        • Platt D.E.
        • Ghassibe-Sabbagh M.
        • Youhanna S.
        • et al.
        Circulating lipid levels and risk of coronary artery disease in a large group of patients undergoing coronary angiography.
        J Thromb Thrombolysis. Jan 2015; 39: 15-22https://doi.org/10.1007/s11239-014-1069-2
        • Calling S.
        • Johansson S.-.E.
        • Wolff M.
        • Sundquist J.
        • Sundquist K.
        Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease: a 17-year follow-up study of women in southern Sweden.
        BMC Cardiovasc Disord. 2021; 21 (163–163)https://doi.org/10.1186/s12872-021-01971-1
        • Hatmi Z.N.
        • Jalilian N.
        • Pakravan A.
        The Relationship Between Premature Myocardial Infarction with TC/HDL-C Ratio Subgroups in a Multiple Risk Factor Model.
        Adv J Emerg Med. 2019; 3 (Summer): e24https://doi.org/10.22114/ajem.v0i0.149
        • Khaw K.T.
        • Sharp S.J.
        • Finikarides L.
        • et al.
        Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women.
        BMJ Open. Mar 6 2018; 8e020167https://doi.org/10.1136/bmjopen-2017-020167
        • Scranton R.
        • Sesso H.D.
        • Stampfer M.J.
        • Levenson J.W.
        • Buring J.E.
        • Gaziano J.M.
        Predictors of 14-year changes in the total cholesterol to high-density lipoprotein cholesterol ratio in men.
        Am Heart J. Jun 2004; 147: 1033-1038https://doi.org/10.1016/j.ahj.2003.11.018
        • Musa D.I.
        • Adeniran S.A.
        • Dikko A.U.
        • Sayers S.P.
        The effect of a high-intensity interval training program on high-density lipoprotein cholesterol in young men.
        J Strength Cond Res. Mar 2009; 23: 587-592https://doi.org/10.1519/JSC.0b013e318198fd28
        • Mackey R.H.
        • Greenland P.
        • Goff Jr., D.C.
        • Lloyd-Jones D.
        • Sibley C.T.
        • Mora S
        High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).
        J Am Coll Cardiol. Aug 7 2012; 60: 508-516https://doi.org/10.1016/j.jacc.2012.03.060
        • Ko D.T.
        • Alter D.A.
        • Guo H.
        • et al.
        High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: the CANHEART Study.
        J Am Coll Cardiol. Nov 8 2016; 68: 2073-2083https://doi.org/10.1016/j.jacc.2016.08.038